The purpose of this webinar is to discuss the FDA’s voluntary medical device manufacturing and product quality pilot program, CMMI Institute’s role in it and how manufacturers will benefit from this program.
Recent negotiations under the Generic Drug User Fee Amendments (GDUFA IV) have revealed tension between the U.S. ...
